SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 635 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 635 | -31.2% | 0.00% | – |
| Q2 2022 | $3,000 | -72.7% | 923 | -54.6% | 0.00% | – |
| Q1 2022 | $11,000 | -26.7% | 2,035 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | -11.8% | 2,035 | +2.2% | 0.00% | – |
| Q3 2021 | $17,000 | +240.0% | 1,991 | +298.2% | 0.00% | – |
| Q2 2021 | $5,000 | -86.5% | 500 | -83.3% | 0.00% | – |
| Q1 2021 | $37,000 | +3600.0% | 3,000 | +2900.0% | 0.00% | – |
| Q4 2020 | $1,000 | -88.9% | 100 | -90.1% | 0.00% | – |
| Q3 2020 | $9,000 | 0.0% | 1,010 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +800.0% | 1,010 | +910.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |